Axogen AXGN

Axogen FY 2024: revenue $187.3M, up 18%; diluted EPS −$0.23

Form
10-K
Filed
Period
Importance
Notable
Document
10-K

Key figures from this report

These are the numbers Axogen reported for the year ended Dec 31, 2024, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Revenue$187.3M+18% from $159.0M in FY 202310-K income statement, on EDGAR
  2. Net income−$10.0MAgainst −$21.7M in FY 202310-K income statement, on EDGAR
  3. Diluted EPS−$0.23Against −$0.51 in FY 202310-K income statement, on EDGAR
  4. Cash and cash equivalents$27.6M−11% from $31.0M in FY 2023Cash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
  5. Cash from operations$4.5MAgainst −$5.7M in FY 202310-K cash flow statement, on EDGAR

Every year in the financial tables

Get an email when Axogen files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3845 and related industry codes: the same peer list as the financial tables.

Data on this page was fetched . The filing on SEC.gov is the record.